Ontology highlight
ABSTRACT: Background
Amyotrophic lateral sclerosis (ALS) is an incurable fatal motoneuron disease with a lifetime risk of approximately 1:400. It is characterized by progressive weakness, muscle wasting, and death ensuing 3-5 years after diagnosis. Granulocyte-colony stimulating factor (G-CSF) is a drug candidate for ALS, with evidence for efficacy from animal studies and interesting data from pilot clinical trials. To gain insight into the disease mechanisms and mode of action of G-CSF, we performed gene expression profiling on isolated lumbar motoneurons from SOD1(G93A) mice, the most frequently studied animal model for ALS, with and without G-CSF treatment.Results
Motoneurons from SOD1(G93A) mice present a distinct gene expression profile in comparison to controls already at an ea
SUBMITTER: Henriques A
PROVIDER: S-EPMC4299451 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature